Skip to content

IMMM 2025 Videos


#stroke

Session 1 - Cerebroprotective treatment strategies after stroke – Evidence from 3 new studies - Introduction

Speaker: Jennifer Manzano
Institution: Head of Asian Hospital and Medical Center – Asian Brain Institute, Metro Manila, Philippines

#stroke

Effect of Cerebrolysin on circulating tight junction proteins after reperfusion therapy

Speaker: Sławomir Michalak
Institution: Institute of Neurological Disorders, Poznan, Poland

#stroke

Cerebroprotection as an adjunct to mechanical thrombectomy

Speaker: Jacek Staszewski
Institution: Military Institute of Medicine, Warsaw, Poland

Speech therapy combined with a cerebroprotective agent enhances aphasia recovery after AIS: Result from the ESCAS study

Speaker: Micha Karlinski
Institution: Institute of Psychiatry and Neurology, Warsaw, Poland

#tbi

TBI-consequences – Updates on essential guideline recommendations in neurorehabilitation

Speaker: Sindi Mitrovic
Institution: Clinic for rehabilitation “Dr Miroslav Zotović” Belgrade, Serbia

#tbi

Session 2 - Advances in brain trauma treatment strategies - Introduction

Speaker: Paschenelle Celis
Institution: Metro North Medical Center And Hospital Inc., Metro Manila, Philippines

#tbi

Clinical benefits of Cerebrolysin treatment in the real world – remarkable recovery after TBI

Speaker: Philipp Li
Institution: Far Eastern Memorial Hospital, New Taipei City, Taiwan

#tbi

Clinical benefits of Cerebrolysin treatment in the real world – recovery after delirium

Speaker: Adel Alansary
Institution: Anesthesiology and Critical Care, Faculty of Medicine Ain Shams University, Abbasia-Cairo, Egypt

#stroke

Expert Panel Discussion

Speaker: Dafin Muresanu, Michael Brainin, Daniel Šaňák, Paschenelle Celis, Paola Marangolo, Philipp Li
Institution:

#neurocognitive disorders

Session 3 - New evidence in post-stroke cognition - Introduction

Speaker: Slaven Pikija
Institution: Medical University of Graz, Universitätsklinik für Department of Neurology, Austria

#neurocognitive disorders

CREGS - Results of a large high-quality comparative effectiveness study

Speaker: Michael Brainin
Institution: Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Austria

#neurocognitive disorders

Cerebrolysin and post stroke cognitive decline – Results from a Mexican retrospective cohort

Speaker: Manuel Martinez
Institution: Neurology Department, Hospital Universitario de la UAdeC, Saltillo, México

#neurocognitive disorders

Post-stroke cognitive assessments – Essentials for the acute and subacute phase

Speaker: Sigrid Schwarz
Institution: Universitätsklinikum Tulln, Austria

#stroke

Speech therapy combined with a cerebroprotective agent enhances aphasia recovery after AIS: Results from the ESCAS study

Speaker: Dafin Muresanu
Institution: Chairman Department of Neurosciences, University of Medicine and Pharmacy ‘Iuliu Hatieganu’, Cluj-Napoca, Romania